NovaBridge Biosciences (NBP) Return on Capital Employed (2020 - 2025)
NovaBridge Biosciences (NBP) reported Return on Capital Employed of 38.94% for Q4 2025, down 1494.0% year-over-year from 2.79% in Q4 2024, and down 153.3% on a QoQ basis from 15.37% in Q3 2025.
NovaBridge Biosciences (NBP) has 4 years of Return on Capital Employed data on file, last reported at 38.94% in Q4 2025.
- Quarterly Return on Capital Employed fell 1494.0% year-over-year to 38.94% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 38.94% (down 1494.0% YoY) and the FY2025 annual result came in at 44.95%, down 2674.0% from the prior year.
- Return on Capital Employed declined to 38.94% in Q4 2025 per NBP's latest filing, from 15.37% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 20235.05% in Q2 2023 and bottomed at 38.94% in Q4 2025.
- The 3-year median for Return on Capital Employed is 23.73% (2025), against an average of 2868.64%.
- Peak annual rise in Return on Capital Employed reached 1811 bps in 2025, while the deepest fall reached 1494 bps in 2025.
- Tracing NBP's Return on Capital Employed over 3 years: stood at 20235.05% in 2023, then slumped by 100 bps to 24.01% in 2024, then plunged by 62 bps to 38.94% in 2025.
- Per Business Quant, the three latest NBP Return on Capital Employed figures stand at 38.94% (Q4 2025), 15.37% (Q3 2025), and 19.04% (Q2 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.94% |
| Sep 30, 2025 | -15.37% |
| Jun 30, 2025 | -19.04% |
| Mar 31, 2025 | -23.73% |
| Dec 31, 2024 | -24.01% |
| Sep 30, 2024 | -33.49% |
| Jun 30, 2023 | 20,235.05% |
| Dec 31, 2020 | 12,497.49% |